Martine A. Rothblatt's most recent trade in United Therapeutics Corp was a trade of 7,782 Common Stock done at an average price of $135.4 . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 15 Jul 2026 | 7,782 | 332,225 (0%) | 0% | 135.4 | 1,053,838 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 7,782 | 341,410 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 531.97 per share. | 15 Jul 2026 | 3,295 | 325,388 (0%) | 0% | 532.0 | 1,752,834 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 1,718 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 15 Jul 2026 | 1,718 | 42,231 (0%) | 0% | 135.4 | 232,652 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 531.03 per share. | 15 Jul 2026 | 1,044 | 328,683 (0%) | 0% | 531.0 | 554,391 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 533.08 per share. | 15 Jul 2026 | 825 | 324,563 (0%) | 0% | 533.1 | 439,791 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 532.06 per share. | 15 Jul 2026 | 800 | 40,713 (0%) | 0% | 532.1 | 425,647 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 529.03 per share. | 15 Jul 2026 | 641 | 330,304 (0%) | 0% | 529.0 | 339,106 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 530.12 per share. | 15 Jul 2026 | 577 | 329,727 (0%) | 0% | 530.1 | 305,878 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 524.40 per share. | 15 Jul 2026 | 440 | 331,345 (0%) | 0% | 524.4 | 230,734 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 525.24 per share. | 15 Jul 2026 | 280 | 331,065 (0%) | 0% | 525.2 | 147,066 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 530.97 per share. | 15 Jul 2026 | 278 | 41,513 (0%) | 0% | 531.0 | 147,609 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 523.20 per share. | 15 Jul 2026 | 203 | 331,785 (0%) | 0% | 523.2 | 106,210 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 521.84 per share. | 15 Jul 2026 | 189 | 331,988 (0%) | 0% | 521.8 | 98,628 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 533.22 per share. | 15 Jul 2026 | 160 | 40,553 (0%) | 0% | 533.2 | 85,315 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 529.67 per share. | 15 Jul 2026 | 120 | 41,791 (0%) | 0% | 529.7 | 63,560 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 523.98 per share. | 15 Jul 2026 | 120 | 42,031 (0%) | 0% | 524.0 | 62,877 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 527.77 per share. | 15 Jul 2026 | 120 | 330,945 (0%) | 0% | 527.8 | 63,332 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 534.28 per share. | 15 Jul 2026 | 120 | 324,443 (0%) | 0% | 534.3 | 64,113 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 525.42 per share. | 15 Jul 2026 | 80 | 41,951 (0%) | 0% | 525.4 | 42,034 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 521.82 per share. | 15 Jul 2026 | 80 | 42,151 (0%) | 0% | 521.8 | 41,746 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 520.92 per share. | 15 Jul 2026 | 48 | 332,177 (0%) | 0% | 520.9 | 25,004 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 534.10 per share. | 15 Jul 2026 | 40 | 40,513 (0%) | 0% | 534.1 | 21,364 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 527.55 per share. | 15 Jul 2026 | 40 | 41,911 (0%) | 0% | 527.6 | 21,102 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 14 Jul 2026 | 9,500 | 50,013 (0%) | 0% | 135.4 | 1,286,490 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2026 | 9,500 | 1,718 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 526.13 per share. | 14 Jul 2026 | 3,492 | 44,213 (0%) | 0% | 526.1 | 1,837,255 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 525.16 per share. | 14 Jul 2026 | 1,468 | 47,705 (0%) | 0% | 525.2 | 770,940 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 527.06 per share. | 14 Jul 2026 | 1,220 | 42,993 (0%) | 0% | 527.1 | 643,010 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 529.21 per share. | 14 Jul 2026 | 959 | 41,374 (0%) | 0% | 529.2 | 507,512 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 524.15 per share. | 14 Jul 2026 | 840 | 49,173 (0%) | 0% | 524.1 | 440,284 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 528.13 per share. | 14 Jul 2026 | 660 | 42,333 (0%) | 0% | 528.1 | 348,569 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 530.67 per share. | 14 Jul 2026 | 554 | 40,820 (0%) | 0% | 530.7 | 293,993 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 532.60 per share. | 14 Jul 2026 | 200 | 40,513 (0%) | 0% | 532.6 | 106,520 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 531.08 per share. | 14 Jul 2026 | 107 | 40,713 (0%) | 0% | 531.1 | 56,826 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 13 Jul 2026 | 9,500 | 50,013 (0%) | 0% | 135.4 | 1,286,490 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2026 | 9,500 | 11,218 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 534.63 per share. | 13 Jul 2026 | 2,272 | 46,721 (0%) | 0% | 534.6 | 1,214,669 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 536.52 per share. | 13 Jul 2026 | 2,223 | 42,307 (0%) | 0% | 536.5 | 1,192,674 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 535.47 per share. | 13 Jul 2026 | 2,191 | 44,530 (0%) | 0% | 535.5 | 1,173,213 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 533.70 per share. | 13 Jul 2026 | 1,020 | 48,993 (0%) | 0% | 533.7 | 544,376 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 537.66 per share. | 13 Jul 2026 | 665 | 41,642 (0%) | 0% | 537.7 | 357,545 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 538.60 per share. | 13 Jul 2026 | 409 | 41,233 (0%) | 0% | 538.6 | 220,289 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 541.10 per share. | 13 Jul 2026 | 360 | 40,553 (0%) | 0% | 541.1 | 194,796 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 539.60 per share. | 13 Jul 2026 | 320 | 40,913 (0%) | 0% | 539.6 | 172,673 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 542.80 per share. | 13 Jul 2026 | 40 | 40,513 (0%) | 0% | 542.8 | 21,712 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 10 Jul 2026 | 9,500 | 50,013 (0%) | 0% | 135.4 | 1,286,490 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2026 | 9,500 | 20,718 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 542.49 per share. | 10 Jul 2026 | 1,870 | 46,573 (0%) | 0% | 542.5 | 1,014,451 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 547.17 per share. | 10 Jul 2026 | 1,578 | 40,993 (0%) | 0% | 547.2 | 863,440 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 545.54 per share. | 10 Jul 2026 | 1,524 | 44,009 (0%) | 0% | 545.5 | 831,409 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 546.42 per share. | 10 Jul 2026 | 1,438 | 42,571 (0%) | 0% | 546.4 | 785,750 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 541.47 per share. | 10 Jul 2026 | 970 | 48,443 (0%) | 0% | 541.5 | 525,226 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 543.34 per share. | 10 Jul 2026 | 676 | 45,897 (0%) | 0% | 543.3 | 367,296 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 540.37 per share. | 10 Jul 2026 | 600 | 49,413 (0%) | 0% | 540.4 | 324,223 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 548.44 per share. | 10 Jul 2026 | 400 | 40,593 (0%) | 0% | 548.4 | 219,375 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 544.54 per share. | 10 Jul 2026 | 364 | 45,533 (0%) | 0% | 544.5 | 198,212 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 553.48 per share. | 10 Jul 2026 | 80 | 40,513 (0%) | 0% | 553.5 | 44,278 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 09 Jul 2026 | 9,500 | 50,013 (0%) | 0% | 135.4 | 1,286,490 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 9,500 | 30,218 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 551.03 per share. | 09 Jul 2026 | 2,863 | 43,722 (0%) | 0% | 551.0 | 1,577,611 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 552.38 per share. | 09 Jul 2026 | 1,648 | 42,074 (0%) | 0% | 552.4 | 910,323 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 549.01 per share. | 09 Jul 2026 | 1,536 | 48,037 (0%) | 0% | 549.0 | 843,273 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 550.12 per share. | 09 Jul 2026 | 1,452 | 46,585 (0%) | 0% | 550.1 | 798,780 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 553.29 per share. | 09 Jul 2026 | 801 | 41,273 (0%) | 0% | 553.3 | 443,185 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 554.22 per share. | 09 Jul 2026 | 640 | 40,633 (0%) | 0% | 554.2 | 354,704 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 548.16 per share. | 09 Jul 2026 | 440 | 49,573 (0%) | 0% | 548.2 | 241,189 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 555.77 per share. | 09 Jul 2026 | 120 | 40,513 (0%) | 0% | 555.8 | 66,692 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2026 | 9,500 | 39,718 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 08 Jul 2026 | 9,500 | 50,013 (0%) | 0% | 135.4 | 1,286,490 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 553.42 per share. | 08 Jul 2026 | 1,710 | 43,543 (0%) | 0% | 553.4 | 946,350 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 552.51 per share. | 08 Jul 2026 | 1,490 | 45,253 (0%) | 0% | 552.5 | 823,241 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 554.45 per share. | 08 Jul 2026 | 1,118 | 42,425 (0%) | 0% | 554.5 | 619,880 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 551.56 per share. | 08 Jul 2026 | 925 | 46,743 (0%) | 0% | 551.6 | 510,190 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 549.52 per share. | 08 Jul 2026 | 923 | 48,453 (0%) | 0% | 549.5 | 507,210 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 550.45 per share. | 08 Jul 2026 | 785 | 47,668 (0%) | 0% | 550.4 | 432,101 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 557.82 per share. | 08 Jul 2026 | 702 | 41,053 (0%) | 0% | 557.8 | 391,591 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 548.62 per share. | 08 Jul 2026 | 637 | 49,376 (0%) | 0% | 548.6 | 349,472 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 556.64 per share. | 08 Jul 2026 | 379 | 41,755 (0%) | 0% | 556.6 | 210,967 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 560.79 per share. | 08 Jul 2026 | 320 | 40,513 (0%) | 0% | 560.8 | 179,454 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 555.75 per share. | 08 Jul 2026 | 291 | 42,134 (0%) | 0% | 555.8 | 161,724 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 558.79 per share. | 08 Jul 2026 | 220 | 40,833 (0%) | 0% | 558.8 | 122,933 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 07 Jul 2026 | 9,500 | 50,013 (0%) | 0% | 135.4 | 1,286,490 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2026 | 9,500 | 49,218 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 559.76 per share. | 07 Jul 2026 | 3,399 | 41,880 (0%) | 0% | 559.8 | 1,902,629 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 558.90 per share. | 07 Jul 2026 | 1,875 | 45,279 (0%) | 0% | 558.9 | 1,047,938 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 557.78 per share. | 07 Jul 2026 | 1,096 | 47,154 (0%) | 0% | 557.8 | 611,324 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 562.60 per share. | 07 Jul 2026 | 800 | 40,575 (0%) | 0% | 562.6 | 450,077 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 556.55 per share. | 07 Jul 2026 | 726 | 48,250 (0%) | 0% | 556.6 | 404,058 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 555.50 per share. | 07 Jul 2026 | 596 | 48,976 (0%) | 0% | 555.5 | 331,079 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 560.49 per share. | 07 Jul 2026 | 505 | 41,375 (0%) | 0% | 560.5 | 283,048 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 554.36 per share. | 07 Jul 2026 | 241 | 49,572 (0%) | 0% | 554.4 | 133,600 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 553.12 per share. | 07 Jul 2026 | 200 | 49,813 (0%) | 0% | 553.1 | 110,623 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 563.24 per share. | 07 Jul 2026 | 62 | 40,513 (0%) | 0% | 563.2 | 34,921 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 06 Jul 2026 | 9,500 | 50,013 (0%) | 0% | 135.4 | 1,286,490 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2026 | 9,500 | 58,718 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 549.03 per share. | 06 Jul 2026 | 3,354 | 43,530 (0%) | 0% | 549.0 | 1,841,459 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 549.87 per share. | 06 Jul 2026 | 2,116 | 41,414 (0%) | 0% | 549.9 | 1,163,515 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 546.93 per share. | 06 Jul 2026 | 2,098 | 47,915 (0%) | 0% | 546.9 | 1,147,468 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 548.00 per share. | 06 Jul 2026 | 1,031 | 46,884 (0%) | 0% | 548 | 564,988 | Common Stock |